FDA
-
-
-
-
-
-
-
CytoSorbents posts flat Q4 revenue of $9.2 million, plans FDA filing
-
-
-
-
-
-
-
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen
-
-
-
-
-
-
-
CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
CytoSorbents to Participate at the Jefferies Global Healthcare Conference
-
-
-
-
-
-
-
Cytosorbents (CTSO) Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program
-
-
-
-
-
-
-
CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit
-
-
-
-
-
-
-
Cytosorbents (CTSO) Opens New Regional Sales Subsidiary in Dubai
-
323,580 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

